Each year, 9 million people are infected with a Mycobacterium tuberculosis infection globally. TB causes about 1.5 million deaths per year which is more than any other infectious disease. The treatment of TB is complex and takes long. Even treatment of drug-sensitive disease generally lasts for six months. Efforts to shorten regimens have proved unpromising and treatment outcome of TB also remains difficult to predict. Even though such predictions could support research and development focused on treatment shortening and personalisation. This partnership award will undertake the groundwork for future TB patient cohorts in London and Seoul through capacity building.